Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01663246 · ClinicalTrials.gov registry record · NA

Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer

A NA study of Head and Neck Cancer, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01663246 is a NA study of Head and Neck Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 50 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01663246, a NA study of Head and Neck Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigators are conducting research about oral health and saliva to find out more about the impact of radiation therapy on the oral health of patients. In order to better understand the role of saliva in maintaining oral health in these patients, the investigators will be collecting, storing, and analyzing the quality of saliva, including the protein content, collected from patients following radiation therapy as well as saliva collected from normal healthy adults.

Conditions Studied

Interventions

  • PROCEDURE Saliva Sample

Study Locations (1)

Michigan

  • University of Michigan Comprehensive Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2006-04
Est. Completion 2008-12
Phase NA

What the Registry Record Tells You About NCT01663246

The ClinicalTrials.gov registry entry for NCT01663246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (81% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Saliva Sample is the first listed.

NCT01663246 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT01663246 about?

NCT01663246 is a clinical study titled "Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer". The investigators are conducting research about oral health and saliva to find out more about the impact of radiation therapy on the oral health of patients. In order to better understand the role of saliva in maintaining oral health in these patients, the investigators will be collecting, storing,...

What is the current status of trial NCT01663246?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2006-04. Estimated completion is 2008-12.

What conditions does trial NCT01663246 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT01663246?

The interventions under investigation include: Saliva Sample (PROCEDURE).

Who is sponsoring clinical trial NCT01663246?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01663246 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.